Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Federman, Noah ^a   Chan, Jason ^a   Nagy, Jon O ^b   Landaw, Elliot M ^c   McCabe, Katelyn ^c   Wu, Anna M ^c   Triche, Timothy ^d   Kang, Hyunggyoo ^d   Liu, Bin ^e   Marks, James D ^e   Denny, Christopher T ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NanoValent Pharmaceuticals Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; DOXORUBICIN; LIPOSOME; NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG TARGETING; HUMAN; HUMAN TISSUE; OSTEOSARCOMA; PRIORITY JOURNAL;

EID: 84867320849     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/126906     Document Type: Article

References (32)

1. Huvos A. G., Bone Tumors: Diagnosis, Treatment, and Prognosis 1991 Philadelphia, Pa, USA WB Saunders
2. Dahlin D. C., Unni K. K., Osteosarcoma of bone and its important recognizable varieties. American Journal of Surgical Pathology 1977 1 1 61 72 2-s2.0-0017465005
3. Gurney J. G., Swensen A. R., Bulterys M., Malignant bone tumors. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 19751995 1999 Bethesda, Md, USA SEER program, National Cancer Institute 99 110
4. Janeway K. A., Grier H. E., Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. The Lancet Oncology 2010 11 7 670 678 2-s2.0-77954031237 10.1016/S1470-2045(10)70062-0
5. Puri A., Loomis K., Smith B., Lee J. H., Yavlovich A., Heldman E., Blumenthal R., Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Critical Reviews in Therapeutic Drug Carrier Systems 2009 26 6 523 580 2-s2.0-77951690744
6. Lindner L. H., Hossann M., Factors affecting drug release from liposomes. Current Opinion in Drug Discovery and Development 2010 13 1 111 123 2-s2.0-73849121484
7. Andresen T. L., Jensen S. S., Jorgensen K., Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Progress in Lipid Research 2005 44 1 68 97 2-s2.0-14644399827 10.1016/j.plipres.2004.12.001 (Pubitemid 40313220)
8. Allen T. M., Ligand-targeted therapeutics in anticancer therapy. Nature Reviews Cancer 2002 2 10 750 763 2-s2.0-0036781811 10.1038/nrc903 (Pubitemid 37328910)
9. Swart G. W. M., Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. European Journal of Cell Biology 2002 81 6 313 321 2-s2.0-0035985278 (Pubitemid 34692942)
10. Ofori-Acquah S. F., King J. A., Activated leukocyte cell adhesion molecule: a new paradox in cancer. Translational Research 2008 151 3 122 128 2-s2.0-38949171709 10.1016/j.trsl.2007.09.006 (Pubitemid 351221436)
11. Kristiansen G., Pilarsky C., Wissmann C., Stephan C., Weissbach L., Loy V., Loening S., Dietel M., Rosenthal A., ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 2003 54 1 34 43 2-s2.0-0037218432 10.1002/pros.10161 (Pubitemid 36043834)
12. King J. A., Ofori-Acquah S. F., Stevens T., Al-Mehdi A. B., Fodstad O., Jiang W. G., Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Research 2004 6 5 R478 R487 2-s2.0-4644299282
13. Liu B., Roth A., Drummond D. C., Conrad F., Hayes M. E., Kirpotin D. B., Benz C. C., Marks J. D., Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells. Molecular Cancer Therapeutics 2007 6 10 2737 2746 2-s2.0-35848955441 10.1158/1535-7163.MCT-07- 0140 (Pubitemid 350058154)
14. Bruehl R. E., Dasgupta F., Katsumoto T. R., Tan J. H., Bertozzi C. R., Spevak W., Ahn D. J., Rosen S. D., Nagy J. O., Polymerized liposome assemblies: bifunctional macromolecular selectin inhibitors mimicking physiological selectin ligands. Biochemistry 2001 40 20 5964 5974 2-s2.0-0035918529 10.1021/bi002921s (Pubitemid 32466298)
15. Nelissen J. M. D. T., Torensma R., Pluyter M., Adema G. J., Raymakers R. A. P., van Kooyk Y., Figdor C. G., Molecular analysis of the hematopoiesis supporting osteoblastic cell line U2-OS. Experimental Hematology 2000 28 4 422 432 2-s2.0-0034055008 10.1016/S0301-472X(00)00127-2 (Pubitemid 30214154)
16. Olmsted J., Strand M., Fluorescence of polymerized diacetylene bilayer films. Journal of Physical Chemistry 1983 87 24 4790 4792 2-s2.0-0000311198
17. Eckhardt H., Boudreaux D. S., Chance R. R., Effects of substituent-induced strain on the electronic structure of polydiacetylenes. The Journal of Chemical Physics 1986 85 7 4116 4119 2-s2.0-4444374312
18. Liu B., Conrad F., Roth A., Drummond D. C., Simko J. P., Marks J. D., Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer. Journal of Molecular Medicine 2007 85 10 1113 1123 2-s2.0-34748837359 10.1007/s00109-007-0208-z (Pubitemid 47476727)
19. McCabe K. E., Liu B., Marks J. D., Tomlinson J. S., Wu H., Wu A. M., An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors. Molecular Imaging and Biology 2012 14 3 336 347 2-s2.0-79957551447 10.1007/s11307-011-0500-8
20. Barat B., Sirk S. J., McCabe K. E., Li J., Lepin E. J., Remenyi R., Koh A. L., Olafsen T., Gambhir S. S., Weiss S., Wu A. M., Cys-diabody quantum dot conjugates (ImmunoQdots) for cancer marker detection. Bioconjugate Chemistry 2009 20 8 1474 1481 2-s2.0-70349090157 10.1021/bc800421f
21. Haran G., Cohen R., Bar L. K., Barenholz Y., Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochimica et Biophysica Acta 1993 1151 2 201 215 (Pubitemid 23283973)
22. Ishida T., Kirchmeier M. J., Moase E. H., Zalipsky S., Allen T. M., Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochimica et Biophysica Acta 2001 1515 2 144 158 2-s2.0-0035575844 10.1016/S0005-2736(01)00409-6 (Pubitemid 33086831)
23. Bowen M. A., Aruffo A., Adhesion molecules, their receptors, and their regulation: analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions. Transplantation Proceedings 1999 31 1-2 795 796 2-s2.0-0032985852 10.1016/S0041-1345(98)01773-4 (Pubitemid 29127679)
24. van Kempen L. C. L. T., van den Oord J. J., van Muijen G. N. P., Weidle U. H., Bloemers H. P. J., Swart G. W. M., Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. American Journal of Pathology 2000 156 3 769 774 2-s2.0-0033898112 (Pubitemid 30626933)
25. Cabral E. C. M., Hennies P. T., Correia C. R. D., Zollner R. L., Santana M. H. A., Preparation and characterization of diacetylene polymerized liposomes for detection of autoantibodies. Journal of Liposome Research 2003 13 3-4 199 211 2-s2.0-0344851802 (Pubitemid 37486240)
26. Sipkins D. A., Cheresh D. A., Kazemi M. R., Nevin L. M., Bednarski M. D., Li K. C. P., Detection of tumor angiogenesis in vivo by α (v) β 3-targeted magnetic resonance imaging. Nature Medicine 1998 4 5 623 626 2-s2.0-0031862889 10.1038/nm0598-623 (Pubitemid 28237365)
27. Guo C., Liu S., Dai Z., Jiang C., Li W. Y., Polydiacetylene vesicles as a novel drug sustained-release system. Colloids and Surfaces B 2010 76 1 362 365 2-s2.0-74149093651 10.1016/j.colsurfb.2009.10.009
28. Puri A., Yavlovich A., Singh A., Blumenthal R., A novel class of photo-triggerable liposomes containing DPPC:DC 8,9PC as vehicles for delivery of doxorubcin to cells. Biochimica et Biophysica Acta 2011 1808 1 117 126 2-s2.0-78649787234 10.1016/j.bbamem.2010.07.030
29. Li Z., Qin G. T., Xia R. M., Li F., O'Neill B. E., Goodwin J. T., Khant H. A., Chiu W., Li K. C., Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery. Nanotechnology 2011 22 15 2-s2.0-79952662628 10.1088/0957-4484/22/15/ 155605 155605
30. de Menezes D. E. L., Kirchmeier M. J., Gagne J. F., Pilarski L. M., Allen T. M., Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells. Journal of Liposome Research 1999 9 2 199 228 2-s2.0-0033043410 (Pubitemid 29289785)
31. Moran-Mirabal J. M., Aubrecht D. M., Craighead H. G., Phase separation and fractal domain formation in phospholipid/diacetylene-supported lipid bilayers. Langmuir 2007 23 21 10661 10671 2-s2.0-35448986477 10.1021/la701371f (Pubitemid 47623241)
32. Gomes C. M. F., van Paassen H., Romeo S., Welling M. M., Feitsma R. I. J., Abrunhosa A. J., Botelho M. F., Hogendoorn P. C. W., Pauwels E., Cleton-Jansen A. M., Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies. Nuclear Medicine and Biology 2006 33 7 831 840 2-s2.0-33749426881 10.1016/j.nucmedbio.2006.07.011 (Pubitemid 44512136)